Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Other Non Operating Income for 6 consecutive years, with $258000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 47.45% year-over-year to $258000.0, compared with a TTM value of $8.8 million through Dec 2025, up 97.2%, and an annual FY2025 reading of $8.8 million, up 97.2% over the prior year.
  • Other Non Operating Income was $258000.0 for Q4 2025 at Cytek Biosciences, down from $1.3 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.7 million in Q2 2025 and bottomed at -$615000.0 in Q1 2021.
  • Average Other Non Operating Income over 5 years is $1.0 million, with a median of $657000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income crashed 312.43% in 2021, then soared 6291.38% in 2025.
  • Year by year, Other Non Operating Income stood at -$399000.0 in 2021, then surged by 624.06% to $2.1 million in 2022, then surged by 52.75% to $3.2 million in 2023, then tumbled by 84.63% to $491000.0 in 2024, then crashed by 47.45% to $258000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CTKB at $258000.0 in Q4 2025, $1.3 million in Q3 2025, and $3.7 million in Q2 2025.